skip to Main Content
I-MED PHARMA OPENS EUROPEAN WAREHOUSE

I-MED PHARMA OPENS EUROPEAN WAREHOUSE

I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the opening of a European warehouse located in The Netherlands. This strategic location provides excellent connections to the rest of the world to better serve their international clientele. Shipments from this warehouse will go into effect on April 1st, 2021.

Philipp Binder, President and Chief Operations Officer of I-MED Pharma stated, “As we continue to expand our international footprint, it is imperative that we take strategic decisions that will lead to continued growth and success as a leader in the global dry eye market.  With the representation of our products in over 30 countries, now is the right time for us to have a warehouse outside of North America, which will allow for improved logistics and the best customer experience for our international clients.”

This warehouse will ship products from both the I-MED Pharma and I-MED Animal Health divisions.

I-MED Pharma will continue to focus its strategic efforts on its dry eye product portfolio and believe this new change will further strengthen its leadership position as one of the top global providers of ocular surface disease solutions.

About I-MED Pharma

I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec. As a research-based firm with the vision to be the most important dry eye and ocular surface disease company in the world, I-MED Pharma provides innovative OSD solutions to the global optometry and ophthalmology community.  Through the years, I-MED Pharma has continuously invested heavily in R&D and has created unique and effective products for the management of dry eye disease. A pioneer in the field of artificial tears and ocular hygiene cleansers, I-MED Pharma’s signature product lines include I-DROP® and I-LID ’N LASH®, which are sold around the world.

I-MED Pharma offers a complete range of ocular surface disorder products, including diagnostic tools,  artificial tearsdry eye ointment, ocular hygiene cleanserspunctum plugsnutritional supplements, therapeutic accessories, as well as the E-Eye IRPL®, a long-lasting solution designed specifically for the treatment of dry eyes due to Meibomian Gland Dysfunction.

For more information, please email media@imedpharma.com or visit www.imedpharma.com

Back To Top